UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000020080
Receipt number R000023191
Scientific Title Research on test battery to evaluate subjective and objective hearing of hearing aid users
Date of disclosure of the study information 2016/01/04
Last modified on 2017/12/06 19:46:21

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Research on test battery to evaluate subjective and objective hearing of hearing aid users

Acronym

Test battery for hearing aid users

Scientific Title

Research on test battery to evaluate subjective and objective hearing of hearing aid users

Scientific Title:Acronym

Test battery for hearing aid users

Region

Japan


Condition

Condition

hearing loss

Classification by specialty

Oto-rhino-laryngology

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

Perform subjective and objective hearing test on hearing aid users and to determine the appropriate test battery to evaluate hearing aids.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

CI2004 Japanese speech recognition test score.

Key secondary outcomes

Pure tone audiogram, monosyllable recognition test under hearing aid, Speech, Spatial and Qualities of Hearing scale (SSQ) results.


Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Self control

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Treatment

Type of intervention

Other

Interventions/Control_1

Evaluate Japanese speech recognition ability of hearing aid users using a test (CI2004) designed for cochlear implant users.

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

1. Able to understand and decide.
2. Native Japanese speaker.
3. Bilateral hearing loss with >= 45dB hearing threshold in 3-frequency average in both ears.
4. Maximum speech recognition >= 50% at least in one ear.
5. Speech recognition at 50dB <= 50% at least in one ear.
6. Provide written informed consent.

Key exclusion criteria

1. Poor overall health that makes 3 sets of extensive hearing tests invasive.
2. Hearing loss due to bilateral acoustic neuroma.
3. Hearing loss due to intracranial surgery.
4. Hearing loss due to cranial trauma.
5. Scheduled chemotherapy that includes ototoxic anticancer drugs during the research period.
6. Other medical condition that a doctor decides inappropriate to include in the study.

Target sample size

20


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Torahiko Nakashima

Organization

Kyushu University Hospital

Division name

Department of Otorhinolaryngology

Zip code


Address

3-1-1 Maidashi Higashi-ku Fukuoka

TEL

81-92-642-5668

Email

nakatora@med.kyushu-u.ac.jp


Public contact

Name of contact person

1st name
Middle name
Last name Nozomu Matsumoto

Organization

Kyushu University Hospital

Division name

Department of Otorhinolaryngology

Zip code


Address

3-1-1 Maidashi Higashi-ku Fukuoka

TEL

81-92-642-5668

Homepage URL


Email

matunozo@med.kyushu-u.ac.jp


Sponsor or person

Institute

Kyushu University Hospital

Institute

Department

Personal name



Funding Source

Organization

Oticon Japan

Organization

Division

Category of Funding Organization

Profit organization

Nationality of Funding Organization



Other related organizations

Co-sponsor

Oticon Japan

Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2016 Year 01 Month 04 Day


Related information

URL releasing protocol


Publication of results

Published


Result

URL related to results and publications

https://www.ncbi.nlm.nih.gov/pubmed/29157624

Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2016 Year 01 Month 04 Day

Date of IRB


Anticipated trial start date

2016 Year 02 Month 04 Day

Last follow-up date

2016 Year 12 Month 31 Day

Date of closure to data entry

2017 Year 03 Month 31 Day

Date trial data considered complete

2017 Year 03 Month 31 Day

Date analysis concluded

2017 Year 03 Month 31 Day


Other

Other related information



Management information

Registered date

2015 Year 12 Month 05 Day

Last modified on

2017 Year 12 Month 06 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000023191


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name